Real-world outcomes of mepolizumab in severe eosinophilic asthma: a retrospective cohort study

Fernandes1, Pedro; Sousa1, Marta; Silva1, João Paulo; Belo1, Teresa; Ferro1, Rita; Correia1, António Reis; Correia1, Ana Luís

doi:https://dx.doi.org/10.36416/1806-3756/e20250052

3346
Views

Back to summary

Open Access

Peer-Reviewed
Artigo Original

Real-world outcomes of mepolizumab in severe eosinophilic asthma: a retrospective cohort study

Pedro Fernandes1, Marta Sousa1, João Paulo Silva1, Teresa Belo1, Rita Ferro1, António Reis Correia1, Ana Luís Correia1

DOI: https://dx.doi.org/10.36416/1806-3756/e20250052

1. Centro Hospitalar Tondela-Viseu, Viseu, Portugal.
Submitted: 24 March 2025.
Accepted: 26 March 2025.
Study carried out at the Centro Hospitalar Tondela-Viseu, Viseu, Portugal.

Correspondence to:
Pedro Fernandes. Centro Hospitalar Tondela-Viseu, Avenida Rei Dom Duarte, 3504-509, Viseu, Portugal. Telephone: (+35) 1910788985. E-mail: pdsf94@gmail.com.